title: Access to safety data--stockholders versus prescribers.
authors.affiliation: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, USA.
authors.forename: Marc A
authors.initials: MA
authors.lastname: Pfeffer
authors.forename: Marianne B
authors.initials: MB
authors.lastname: Bowler
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D064420:Drug-Related Side Effects and Adverse Reactions; D033161:Government Regulation; D006801:Humans; D007449:Investments / Q000331:legislation & jurisprudence; D007880:Legislation, Drug; D000857:Olfaction Disorders / Q000139:chemically induced; D055553:Prescription Drugs / Q000009:adverse effects*; D035521:Supreme Court Decisions; D014481:United States; D014486:United States Food and Drug Administration; D017967:Zinc Compounds / Q000009:adverse effects
chemical_list: D055553:Prescription Drugs; D017967:Zinc Compounds